Sotera Health Co (SHC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sotera Health Co (SHC) has a cash flow conversion efficiency ratio of 0.047x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($29.43 Million) by net assets ($622.50 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SHC net asset quality index to measure how much of total assets are equity-financed.
Sotera Health Co - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Sotera Health Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Sotera Health Co cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Sotera Health Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sotera Health Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gland Pharma Limited
NSE:GLAND
|
0.057x |
|
Spirit Aerosystems Holdings Inc
NYSE:SPR
|
0.041x |
|
Grupo Aeroportuario del Centro Norte SAB de CV
NASDAQ:OMAB
|
0.137x |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
N/A |
|
Far Eastern New Century Corp
TW:1402
|
0.021x |
|
Dottikon Es Holding AG
SW:DESN
|
0.078x |
|
Sichuan Changhong Electric Co Ltd
SHG:600839
|
0.070x |
|
ACI Worldwide Inc
NASDAQ:ACIW
|
0.043x |
Annual Cash Flow Conversion Efficiency for Sotera Health Co (2018–2025)
The table below shows the annual cash flow conversion efficiency of Sotera Health Co from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Sotera Health Co worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $606.03 Million | $287.19 Million | 0.474x | -14.40% |
| 2024-12-31 | $404.91 Million | $224.16 Million | 0.554x | +266.29% |
| 2023-12-31 | $443.73 Million | $-147.73 Million | -0.333x | -141.95% |
| 2022-12-31 | $350.24 Million | $277.96 Million | 0.794x | +65.21% |
| 2021-12-31 | $586.10 Million | $281.55 Million | 0.480x | +81.09% |
| 2020-12-31 | $454.57 Million | $120.58 Million | 0.265x | +214.11% |
| 2019-12-31 | $-641.13 Million | $149.04 Million | -0.232x | -108.84% |
| 2018-12-31 | $45.49 Million | $119.56 Million | 2.628x | -- |
About Sotera Health Co
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide process… Read more